Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas M Durcan

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
Scientific Reports|August 5, 2025
Transcriptome-based screening in TARDBP/TDP-43 knock-in motor neurons identifies the NEDD8-activating enzyme inhibitor MLN4924Sarah Lépine, Gilles Maussion, Alexandria Schneider, et al.
Elife|November 23, 2023
Scaling of an antibody validation procedure enables quantification of antibody performance in major research applicationsRiham Ayoubi, Joel Ryan, Michael S Biddle, et al.
Stem Cell Reports|February 12, 2022
FOXG1 dose tunes cell proliferation dynamics in human forebrain progenitor cellsNuwan C Hettige, Huashan Peng, Hanrong Wu, et al.
Communications Biology|February 22, 2025
Female mice exhibit resistance to disease progression despite early pathology in a transgenic mouse model inoculated with alpha-synuclein fibrilsStephanie Tullo, Janice Park, Daniel Gallino, et al.
Stem Cell Reports|June 26, 2018
Disruption of GRIN2B Impairs Differentiation in Human NeuronsScott Bell, Gilles Maussion, Malvin Jefri, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Neural cell state modulation by <i>PARK2</i> and dopaminergic neuroprotection by small molecule Parkin agonismYongxing Gong, Armin Bayati, Tyler J Alban, et al.
Nature Cell Biology|February 12, 2026
Glucosylceramide-induced ectosomes propagate pathogenic α-synuclein in Parkinson's diseaseJulie Jacquemyn, Brian Marriott, Jinlan Chang, et al.
Cell Death & Disease|December 3, 2019
Bcl-2-associated athanogene 5 (BAG5) regulates Parkin-dependent mitophagy and cell deathMitchell L De Snoo, Erik L Friesen, Yu Tong Zhang, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Scaling of an antibody validation procedure enables quantification of antibody performance in major research applicationsRiham Ayoubi, Joel Ryan, Michael S Biddle, et al.
Communications Biology|February 20, 2021
Development of an α-synuclein knockdown peptide and evaluation of its efficacy in Parkinson's disease modelsJack Wuyang Jin, Xuelai Fan, Esther Del Cid-Pellitero, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Scientific Reports|August 5, 2025
Transcriptome-based screening in TARDBP/TDP-43 knock-in motor neurons identifies the NEDD8-activating enzyme inhibitor MLN4924Sarah Lépine, Gilles Maussion, Alexandria Schneider, et al.
Elife|November 23, 2023
Scaling of an antibody validation procedure enables quantification of antibody performance in major research applicationsRiham Ayoubi, Joel Ryan, Michael S Biddle, et al.
Stem Cell Reports|February 12, 2022
FOXG1 dose tunes cell proliferation dynamics in human forebrain progenitor cellsNuwan C Hettige, Huashan Peng, Hanrong Wu, et al.
Communications Biology|February 22, 2025
Female mice exhibit resistance to disease progression despite early pathology in a transgenic mouse model inoculated with alpha-synuclein fibrilsStephanie Tullo, Janice Park, Daniel Gallino, et al.
Stem Cell Reports|June 26, 2018
Disruption of GRIN2B Impairs Differentiation in Human NeuronsScott Bell, Gilles Maussion, Malvin Jefri, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Neural cell state modulation by <i>PARK2</i> and dopaminergic neuroprotection by small molecule Parkin agonismYongxing Gong, Armin Bayati, Tyler J Alban, et al.
Nature Cell Biology|February 12, 2026
Glucosylceramide-induced ectosomes propagate pathogenic α-synuclein in Parkinson's diseaseJulie Jacquemyn, Brian Marriott, Jinlan Chang, et al.
Cell Death & Disease|December 3, 2019
Bcl-2-associated athanogene 5 (BAG5) regulates Parkin-dependent mitophagy and cell deathMitchell L De Snoo, Erik L Friesen, Yu Tong Zhang, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Scaling of an antibody validation procedure enables quantification of antibody performance in major research applicationsRiham Ayoubi, Joel Ryan, Michael S Biddle, et al.
Communications Biology|February 20, 2021
Development of an α-synuclein knockdown peptide and evaluation of its efficacy in Parkinson's disease modelsJack Wuyang Jin, Xuelai Fan, Esther Del Cid-Pellitero, et al.
Pageof 12